References
- Aapro M, Jelkmann W, Constantinescu SN, Leyland- Jones B (2012). Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer. Br J Cancer, 106, 1249-58. https://doi.org/10.1038/bjc.2012.42
- Aapro M, Osterborg A, Gascon P, Ludwig H, Beguin Y (2012). Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol, 23, 1954-62. https://doi.org/10.1093/annonc/mds112
- Abdel-Razeq HN (2004). Cancer-related anemia. Saudi Med J, 25, 15-20.
- Achariyapota V, Benjapibal M, Chaopotong P (2010). Prevalence and incidence of anemia in Thai patients with gynecologic cancer. Asian Pac J Cancer Prev, 11, 1229-33.
- Barrett-Lee PJ, Bailey NP, O'Brien ME, Wager E (2000). Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer, 82, 93-7. https://doi.org/10.1054/bjoc.1999.0883
- Barrett-Lee PJ, Ludwig H, Birgegard G, et al (2006). Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia Survey. Oncology, 70, 34-48. https://doi.org/10.1159/000091675
- Bohanes P, Yang D, Chhibar RS, et al (2012). Influence of sex on the survival of patients with esophageal cancer. J Clin Oncol, 30, 2265-72. https://doi.org/10.1200/JCO.2011.38.8751
- Caro JJ, Salas M, Ward A, Goss G (2001). Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer, 91, 2214-21. https://doi.org/10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P
- Gao F, Cheng K, Zhao F, et al (2011). Prevalence and characteristics of anemia in patients with solid cancers at diagnosis in southwest China. Asian Pac J Cancer Prev, 12, 2825-8.
- Groopman JE, Itri LM (1999). Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst, 91, 1616-34. https://doi.org/10.1093/jnci/91.19.1616
- Hassan BA, Yusoff ZB (2011). Treatment patterns and outcomes in management of solid cancer patients suffering from anemia in Penang hospital. Asian Pac J Cancer Prev, 12, 1573-6.
- Hassan BA, Yusoff ZB, Hassali MA, Othman SB (2011). Association and correlation of different chemotherapeutic regimens and doses with onset and severity of anemia among solid cancer patients. Asian Pac J Cancer Prev, 12, 2753-8.
- Knight K, Wade S, Balducci L (2004). Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med, 116, S11-26.
- Kosmidis P, Krzakowski M (2005). Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)? Lung Cancer, 50, 401-12. https://doi.org/10.1016/j.lungcan.2005.08.004
- Ludwig H, Van Belle S, Barrett-Lee P, et al (2004). The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer, 40, 2293-306. https://doi.org/10.1016/j.ejca.2004.06.019
- Mercadante S, Gebbia V, Marrazzo A, Filosto S (2000). Anaemia in cancer: pathophysiology and treatment. Cancer Treat Rev, 26, 303-11. https://doi.org/10.1053/ctrv.2000.0181
- Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL (1990). Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med, 322, 1689-92. https://doi.org/10.1056/NEJM199006143222401
- Owonikoko TK, Ragin CC, Belani CP, et al (2007). Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol, 25, 5570-7. https://doi.org/10.1200/JCO.2007.12.5435
- Pongsanon K, Benjapibal M, Ruengkhachorn I (2011). Prognostic significance of hemoglobin levels in patients with primary epithelial ovarian carcinoma undergoing platinumbased chemotherapy. Asian Pac J Cancer Prev, 12, 131-6.
- Rothmann SA, Weick JK (1981). Cisplatin toxicity for erythroid precursors. N Engl J Med, 304, 360.
- Spivak JL, Gascon P, Ludwig H (2009). Anemia management in oncology and hematology. Oncologist, 14, 43-56. https://doi.org/10.1634/theoncologist.2009-S1-43
- Steensma DP (2008). Is anemia of cancer different from chemotherapy-induced anemia? J Clin Oncol, 26, 1022-4. https://doi.org/10.1200/JCO.2007.15.3874
- Tchekmedyian NS (2002). Anemia in cancer patients: significance, epidemiology, and current therapy. Oncology (Williston Park), 16, 17-24.
- Weiss G, Goodnough LT (2005). Anemia of chronic disease. N Engl J Med, 352, 1011-23. https://doi.org/10.1056/NEJMra041809
- Wilairat W, Benjapibal M (2012). Presence of anemia and poor prognostic factors in patients with endometrial carcinoma. Asian Pac J Cancer Prev, 13, 3187-90. https://doi.org/10.7314/APJCP.2012.13.7.3187
Cited by
- Endostar Combined with Cisplatin Inhibits Tumor Growth and Lymphatic Metastasis of Lewis Lung Carcinoma Xenografts in Mice vol.14, pp.5, 2013, https://doi.org/10.7314/APJCP.2013.14.5.3079
- Hematologic Toxicity in Patients Undergoing Radical Anti-cancer Therapy: A Cross-Sectional Analysis of Patients in an Oncology Ward in India vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3587
- Tumor response and clinical toxicity associated with second-line chemotherapy regimens for advanced non-squamous non-small cell lung cancer: A retrospective cohort study vol.5, pp.5, 2014, https://doi.org/10.1111/1759-7714.12102
- Iron deficiency anemia in gastric cancer vol.30, pp.12, 2018, https://doi.org/10.1097/MEG.0000000000001251